SummaryRMgm-324
|
Successful modification | The gene/parasite could not be changed/generated by the genetic modification. |
The following genetic modifications were attempted | Gene disruption |
Number of attempts to introduce the genetic modification | Unknown |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 19779564 |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
Attempts to generate the mutant parasite were performed by | |
Name PI/Researcher | R.W. Moon; D.A. Baker; O. Billker |
Name Group/Department | Department of Cell and Molecular Biology |
Name Institute | Imperial College London |
City | London |
Country | UK |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_0910300 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1138400 | ||||||||||||||||||||||||
Gene product | guanylyl cyclase | ||||||||||||||||||||||||
Gene product: Alternative name | Guanylyl cyclase alpha, GCα | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | Unknown | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||
Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | An attempt was made to disrupt both PB001219.00.0 and PB000256.00.0 at once | ||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | Unknown | ||||||||||||||||||||||||
Promoter of the selectable marker | Unknown | ||||||||||||||||||||||||
Selection (positive) procedure | Unknown | ||||||||||||||||||||||||
Selection (negative) procedure | Unknown | ||||||||||||||||||||||||
Additional remarks genetic modification | In the paper it is reported that repeated attempts were made to disrupt the gene. No information/details is provided on the number of attempts to disrupt the gene and the construct used to disrupt the gene. An independent unsuccessful attempt to disrupt the guanylyl cyclase-α gene is described in RMgm-323. (gene models GCα: PB001219.00.0, PB000256.00.0) Two different genes with high homology to guanylyl cyclases (GCα and GCβ) have been identified in Plasmodium (GCβ, guanylyl cyclase beta; Gene models for GCß PB000752.03.0; PB300849.03.0; PB001059) | ||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
top of page |